Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARA | Q07869 | 6/20 | 0.45 |
| ▸ | CYP1A1 | P04798 | 2/20 | 0.44 |
| ▸ | CYP1B1 | Q16678 | 2/20 | 0.44 |
| ▸ | THRB | P10828 | 1/20 | 0.43 |
| ▸ | ATM | Q13315 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.42 |
| ▸ | TBXAS1 | P24557 | 2/20 | 0.42 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.41 |
| ▸ | MAOB | P27338 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL867102 | 1.00 | PPARA (0.45) | PPARACYP1A1CYP1B1THRBATM | |
| SCHEMBL864924 | 0.93 | PPARA (0.46) | PPARACYP1A1CYP1B1THRBATM | |
| SCHEMBL2671840 | 0.93 | PPARA (0.46) | PPARACYP1A1CYP1B1THRBATM | |
| SCHEMBL2671839 | 0.93 | PPARA (0.46) | PPARACYP1A1CYP1B1THRBATM | |
| SCHEMBL864925 | 0.93 | PPARA (0.46) | PPARACYP1A1CYP1B1THRBATM | |
| SCHEMBL2672508 | 0.91 | CYP1A1 (0.44) | PPARACYP1A1CYP1B1THRBATM | |
| SCHEMBL2672511 | 0.91 | CYP1A1 (0.44) | PPARACYP1A1CYP1B1THRBATM | |
| SCHEMBL2672288 | 0.89 | PPARA (0.46) | PPARACYP1A1CYP1B1THRBATM | |
| SCHEMBL2672283 | 0.89 | PPARA (0.46) | PPARACYP1A1CYP1B1THRBATM | |
| SCHEMBL679336 | 0.89 | PPARA (0.48) | PPARACYP1A1CYP1B1THRBATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180079961-A1 | PHOTOALIGNMENT COMPOSITION | ROLIC AG (CH) | 2018-03-22 | — | — | US | disclosed |
| US-20170362381-A1 | THERMALLY STABLE ALIGNMENT MATERIALS | ROLIC AG (CH) | 2017-12-21 | — | — | US | disclosed |
| EP-1966119-B1 | PHOTOCROSSLINKABLE MATERIALS | ROLIC AG (CH) | 2016-10-19 | — | — | EP | disclosed |
| WO-2016156079-A1 | PHOTOALIGNMENT COMPOSITION | ROLIC AG (CH) | 2016-10-06 | — | — | WO | disclosed |
| US-8557922-B2 | Photocrosslinkable materials | ROLIC AG (CH) | 2013-10-15 | — | — | US | disclosed |
| US-20130004679-A1 | PHOTOCROSSLINKABLE MATERIALS | ROLIC AG (CH) | 2013-01-03 | — | — | US | disclosed |
| US-8329823-B2 | Photocrosslinkable materials | ROLIC AG (CH) | 2012-12-11 | — | — | US | disclosed |
| US-8173749-B2 | Photocrosslinkable materials | ROLIC AG (CH) | 2012-05-08 | — | — | US | disclosed |
| US-20120076952-A1 | PHOTOCROSSLINKABLE MATERIALS | ROLIC AG (CH) | 2012-03-29 | — | — | US | disclosed |
| EP-2144951-A1 | THERMALLY STABLE ALIGNMENT MATERIALS | Rolic AG (CH) | 2010-01-20 | — | — | EP | disclosed |
| EP-2142957-A1 | METHOD OF UNIFORM AND DEFECT FREE LIQUID CRYSTAL ALIGNING LAYERS | Rolic AG (CH) | 2010-01-13 | — | — | EP | disclosed |
| US-20080293888-A1 | Photocrosslinkable Materials | ROLIC AG (CH) | 2008-11-27 | — | — | US | disclosed |
| WO-2008135131-A1 | THERMALLY STABLE ALIGNMENT MATERIALS | ROLIC AG (CH) | 2008-11-13 | — | — | WO | disclosed |
| WO-2008119449-A1 | METHOD OF UNIFORM AND DEFECT FREE LIQUID CRYSTAL ALIGNING LAYERS | ROLIC AG (CH) | 2008-10-09 | — | — | WO | disclosed |
| EP-1966119-A1 | PHOTOCROSSLINKABLE MATERIALS | Rolic AG (CH) | 2008-09-10 | — | — | EP | disclosed |
| EP-1860094-A1 | Photocrosslinkable materials | Rolic AG (CH) | 2007-11-28 | — | — | EP | disclosed |
| WO-2007071091-A1 | PHOTOCROSSLINKABLE MATERIALS | ROLIC AG (CH) | 2007-06-28 | — | — | WO | disclosed |
| EP-1801097-A1 | Photocrosslinkable materials | Rolic AG (CH) | 2007-06-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080293888-A1 | Photocrosslinkable Materials | DDC, PARG, ALAD | PPARA 1787/4885CYP1A1 3056/4885CYP1B1 2893/4885 |
| US-20120076952-A1 | PHOTOCROSSLINKABLE MATERIALS | DDC, PARG, ALAD | PPARA 1787/4885CYP1A1 3056/4885CYP1B1 2893/4885 |
| US-20130004679-A1 | PHOTOCROSSLINKABLE MATERIALS | DDC, PARG, ALAD | PPARA 1787/4885CYP1A1 3056/4885CYP1B1 2893/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.